Leadership
We are a small team of PhD scientists, and we run the work ourselves.
BiocheMichael Industries now operates as Lodgepole Discovery. It is the same team and the same legal entity, and every agreement already in place stands unchanged.
Michael Holden, PhD
PhD in Chemistry from the University of Denver, where his doctoral work was on tau fibrils. Previously at Regeneron, and Head of Chemistry at BioLoomics. Visiting Scholar at the University of Denver.
Mike Minson, PhD
Cellular biochemist and molecular biologist with a PhD from the University of Colorado Boulder. Previously NGS assay design and validation for FDA submission at ArcherDx, antibody and exosome platform work at Sartorius, and synthetic biology lead at BioLoomics, running binding, internalization and killing assays across ADC discovery campaigns.